#NEWS: We are excited to announce ARS Pharmaceuticals received FDA approval for neffy® (epinephrine nasal spray). This is the first and only epinephrine nasal delivery method approved and a key milestone in our mission to empower at-risk patients and caregivers. Learn more about the #FDAapproval here: https://bit.ly/3yoI4cP #biotechnews #biotech #science #innovation
Thrilled!!! When can we start getting these at our pharmacy?
Congrats and thank you for working so hard to bring an alternative to a needle for delivery of epinephrine to our allergy community!!! As a parent of a teen that has 15 life threatening food allergies… I can say for certain that this is a game changer.
Congratulations team! Your hard work has paid off and we are so excited about what this means for so many people, communities and schools. AND, we look forward to the opportunity to partner, especially in schools.
Congratulations! This is a tremendous step forward for those with severe allergies like my son. Thank you for the persistence and dedication in getting this advancement approved!
I am beyond ecstatic about this news!! I know so many families and friends who will benefit from neffy!! Way to go ARS Pharma!!
Congratulations! As a former EpiPen District Manager who strongly advocated for patients, this is a game changer and great alternative for patients and caregivers to administer in an emergent situation. Kudos to ARS for being this needed product to market.
Congratulations! As a pharmacist and long-time food allergy advocate, I have been eagerly awaiting this announcement! Celebrating with you!
This is amazing. As someone with a severe food allergy. I will be reaching out to my doctor. Hopefully, no more epi-pen. Congratulations.
Congratulations! This will be a game changer.
Chief Commercial Officer (CCO)
2moCongratulations